BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26888013)

  • 21. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
    Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
    Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
    Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
    Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
    Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of fetal hemoglobin in tribal Indian patients with sickle cell anemia.
    Bhanushali AA; Patra PK; Pradhan S; Khanka SS; Singh S; Das BR
    Transl Res; 2015 Jun; 165(6):696-703. PubMed ID: 25651163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
    Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
    Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
    [No Abstract]   [Full Text] [Related]  

  • 26.
    Gardner K; Fulford T; Silver N; Rooks H; Angelis N; Allman M; Nkya S; Makani J; Howard J; Kesse-Adu R; Rees DC; Stuart-Smith S; Yeghen T; Awogbade M; Sangeda RZ; Mgaya J; Patel H; Newhouse S; Menzel S; Thein SL
    Blood Adv; 2018 Feb; 2(3):235-239. PubMed ID: 29437638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients.
    Lai Y; Zhou L; Yi S; Chen Y; Tang Y; Yi S; Yang Z; Wei H; Zheng C; He S
    Blood Cells Mol Dis; 2017 Mar; 63():52-57. PubMed ID: 28160732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.
    Vathipadiekal V; Farrell JJ; Wang S; Edward HL; Shappell H; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Simkin I; Farrer LA; Jiang Z; Luo HY; Huang S; Mostoslavsky G; Murphy GJ; Patra PK; Chui DH; Alsultan A; Al-Ali AK; Sebastiani P; Steinberg MH
    Am J Hematol; 2016 Nov; 91(11):1118-1122. PubMed ID: 27501013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.
    Mtatiro SN; Singh T; Rooks H; Mgaya J; Mariki H; Soka D; Mmbando B; Msaki E; Kolder I; Thein SL; Menzel S; Cox SE; Makani J; Barrett JC
    PLoS One; 2014; 9(11):e111464. PubMed ID: 25372704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
    Allard P; Alhaj N; Lobitz S; Cario H; Jarisch A; Grosse R; Oevermann L; Hakimeh D; Tagliaferri L; Kohne E; Kopp-Schneider A; Kulozik AE; Kunz JB
    Haematologica; 2022 Jul; 107(7):1577-1588. PubMed ID: 34706496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress on genes related to fetal hemoglobin quantitative trait].
    Guo XQ
    Yi Chuan; 2010 Apr; 32(4):295-300. PubMed ID: 20423883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients.
    Upadhye D; Jain D; Trivedi Y; Nadkarni A; Ghosh K; Colah R
    Ann Hematol; 2016 Jun; 95(7):1201-3. PubMed ID: 27098811
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
    Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphism at BCL11A compared to HBS1L-MYB loci explains less of the variance in HbF in patients with sickle cell disease in Cameroon.
    Bitoungui VJ; Ngogang J; Wonkam A
    Blood Cells Mol Dis; 2015 Mar; 54(3):268-9. PubMed ID: 25488618
    [No Abstract]   [Full Text] [Related]  

  • 35. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia
    Heitzer AM; Longoria J; Rampersaud E; Rashkin SR; Estepp JH; Okhomina VI; Wang WC; Raches D; Potter B; Steinberg MH; King AA; Kang G; Hankins JS
    Curr Res Transl Med; 2022 Jul; 70(3):103335. PubMed ID: 35303690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of BCL11A genetic variant (rs11886868) with severity in β-thalassaemia major & sickle cell anaemia.
    Dadheech S; Madhulatha D; Jainc S; Joseph J; Jyothy A; Munshi A
    Indian J Med Res; 2016 Apr; 143(4):449-54. PubMed ID: 27377501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia.
    Makani J; Menzel S; Nkya S; Cox SE; Drasar E; Soka D; Komba AN; Mgaya J; Rooks H; Vasavda N; Fegan G; Newton CR; Farrall M; Thein SL
    Blood; 2011 Jan; 117(4):1390-2. PubMed ID: 21068433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HbF-promoting polymorphisms may specifically reduce the residual risk of cerebral vasculopathy in SCA children with alpha-thalassemia.
    Joly P; Bonello-Palot N; Badens C; Pissard S; Chamouine A; Bernaudin F; Bertrand Y; Connes P; Renoux C
    Clin Hemorheol Microcirc; 2021; 77(3):267-272. PubMed ID: 33216016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression.
    Farrell JJ; Sherva RM; Chen ZY; Luo HY; Chu BF; Ha SY; Li CK; Lee AC; Li RC; Li CK; Yuen HL; So JC; Ma ES; Chan LC; Chan V; Sebastiani P; Farrer LA; Baldwin CT; Steinberg MH; Chui DH
    Blood; 2011 May; 117(18):4935-45. PubMed ID: 21385855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.
    Adekile A
    Med Princ Pract; 2021; 30(3):201-211. PubMed ID: 32892201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.